CROs/Service Providers

Invacare completes sale of medical supplies business to AssuraMed

Wednesday, January 23, 2013 10:56 AM

Invacare, an Elyria, Ohio-based manufacturer and distributor of home and long-term care medical products, has completed the sale of its Invacare Supply Group (ISG) medical supplies business to AssuraMed, a medical supply distributor based in Twinsburg, Ohio, for a purchase price of approximately $150.8 million in cash.

More... »

Almac completes Knowledge Transfer Partnership with Queens University

Wednesday, January 23, 2013 10:28 AM

Global service provider Almac has successfully completed the Knowledge Transfer Partnership (KTP) with Queens University Belfast, to develop, improve and embed bioprocesses in order to facilitate the delivery of novel products for its biocatalysis business. 

More... »

Xceleron, Crystal Pharmatech to improve early clinical development

Wednesday, January 23, 2013 09:59 AM

Xceleron, a Germantown, Md.-based CRO that applies ultra-sensitive analytical technology to novel clinical designs, has formed a partnership with Crystal Pharmatech, a China-based technology-driven research CRO.

More... »

Stryker to make offer for Trauson Holdings

Friday, January 18, 2013 02:21 PM

Stryker, a global medical technology company, will make a voluntary general offer to acquire all shares of Hong Kong-based Trauson Holdings for $0.97 per ordinary share for a total consideration of $764 million in an all cash transaction, representing an enterprise value of approximately $685 million.

More... »

Covance launches five-year collaboration on early clinical research

Friday, January 18, 2013 01:23 PM

Global CRO Covance and the Royal Liverpool and Broadgreen University Hospitals NHS Trust have entered into a five-year exclusive agreement to work together in conducting early clinical trials at the Royal Liverpool University Hospital on behalf of biotechnology and pharmaceutical companies.

More... »

InDevR spins off ViroCyt, raises growth capital

Wednesday, January 16, 2013 11:50 AM

ViroCyt, a privately held life science company, has begun operations after spinning off from InDevR, a developer of advanced life science instrumentation and assays. Concurrent with the formation of ViroCyt, funding was secured from a group of investors led by High Country Venture.

More... »

ERT expands corporate presence in Japan

Wednesday, January 16, 2013 09:26 AM

ERT, a global technology-driven provider of health outcomes research services, has completed registration for Kabushiki Kaisha (KK) in Japan and has formed a fully-owned subsidiary, ERT Asia Group.

More... »

Partners HealthCare, Illumina announce founding members of GeneInsight Network

Monday, January 14, 2013 02:49 PM

Partners HealthCare, a Boston-based integrated health system, and Illumina, a developer, manufacturer and marketer of life science tools and integrated systems, announced the GeneInsight-Illumina Founding Network Members, including the ARUP Laboratories, Mount Sinai Genetic Testing Laboratory, New York Genome Center (NYGC), Partners HealthCare and Illumina.

More... »

Almac doubles drug development capacity with a new non-GMP facility

Monday, January 14, 2013 10:11 AM

Global service provider Almac has expanded its drug product pharmaceutical development services with the creation of a new non-GMP formulation development facility and two new analytical laboratories at its U.K. headquarters in Craigavon.

More... »

Cerner, Icon partner to streamline late-phase research studies

Monday, January 14, 2013 09:14 AM

Cerner, a global innovator in electronic health record (EHR) and research technology, and global CRO Icon have formed an agreement to provide pharmaceutical and device sponsors with late-phase research technology to streamline the collection of information related to the safety, effectiveness and value of their medical products.

More... »